FDA Clarifies Clinical Pharmacology Studies to Support Biosimilarity
As defined by section 351(k) of the Public Health Service (PHS)
Act, a biosimilar product is highly similar to its reference product,
“notwithstanding minor diff eren...
Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.